CleveMed (Cleveland Medical Devices Inc.)转发了
As we mark the fifth anniversary of COVID this month, it’s clear that the pandemic reshaped healthcare permanently, especially in sleep medicine. Since then, CleveMed has conducted over 350,000 home sleep apnea tests, establishing itself as a national leader and a trusted partner for healthcare systems across the country. However, reflecting on our journey and the pivotal role the patients have played in it is worth summarizing. The pandemic accelerated the demand for home-based healthcare solutions, particularly for the millions of undiagnosed sleep apnea patients who already preferred home testing. Yet, specific guidelines for implementing these solutions were not well-defined. Many companies seized the opportunity by offering rapid testing services through independent providers, bypassing local sleep specialists and affiliated hospitals, which disrupted existing patient-doctor relationships. Unlike those competitors, we remained committed to keeping local healthcare systems and sleep providers at the core of patient care. We forged partnerships with both small and large health systems, equipping them with the technology and logistical support they needed while ensuring they retained clinical oversight and care continuity. With double-digit revenue growth every year since COVID, our expansion continues, but our guiding principle remains unchanged: when faced with challenges—like the pandemic—we always start by asking, “What is best for the patient?”